Holocene Advisors LP acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 64,090 shares of the company's stock, valued at approximately $3,358,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Great Valley Advisor Group Inc. purchased a new stake in Astera Labs during the second quarter valued at about $443,000. Bank of New York Mellon Corp bought a new stake in Astera Labs in the second quarter valued at approximately $8,361,000. Legato Capital Management LLC purchased a new stake in Astera Labs during the 2nd quarter valued at $207,000. Strategic Blueprint LLC purchased a new stake in Astera Labs in the 2nd quarter worth approximately $332,000. Finally, Essex Financial Services Inc. purchased a new stake in Astera Labs in the second quarter worth $1,304,000.
Analysts Set New Price Targets
A number of research analysts have issued reports on ALAB shares. Roth Mkm boosted their price objective on shares of Astera Labs from $80.00 to $105.00 and gave the company a "buy" rating in a research report on Tuesday, November 5th. Citigroup started coverage on shares of Astera Labs in a research note on Monday, November 18th. They issued a "buy" rating and a $120.00 price target for the company. Deutsche Bank Aktiengesellschaft increased their target price on Astera Labs from $60.00 to $100.00 and gave the stock a "buy" rating in a research report on Tuesday, November 5th. Needham & Company LLC restated a "buy" rating and set a $65.00 price target on shares of Astera Labs in a research report on Wednesday, October 9th. Finally, Morgan Stanley increased their price objective on Astera Labs from $74.00 to $94.00 and gave the stock an "overweight" rating in a report on Tuesday, November 5th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $94.67.
Get Our Latest Analysis on Astera Labs
Astera Labs Stock Up 5.0 %
Astera Labs stock traded up $5.72 during trading hours on Friday, hitting $120.40. The stock had a trading volume of 4,053,307 shares, compared to its average volume of 3,223,185. The stock's 50-day moving average price is $80.04 and its 200-day moving average price is $62.15. Astera Labs, Inc. has a 12-month low of $36.22 and a 12-month high of $121.20.
Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The company reported $0.23 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.06. The company had revenue of $113.10 million during the quarter, compared to analyst estimates of $97.50 million. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. Astera Labs's revenue was up 47.1% on a year-over-year basis. On average, analysts anticipate that Astera Labs, Inc. will post -0.45 EPS for the current fiscal year.
Insider Activity at Astera Labs
In other Astera Labs news, insider Sanjay Gajendra sold 740,000 shares of Astera Labs stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $96.59, for a total value of $71,476,600.00. Following the completion of the sale, the insider now owns 775,000 shares of the company's stock, valued at approximately $74,857,250. The trade was a 48.84 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Manuel Alba sold 63,000 shares of the business's stock in a transaction on Friday, September 20th. The shares were sold at an average price of $50.00, for a total transaction of $3,150,000.00. Following the sale, the director now owns 506,863 shares of the company's stock, valued at approximately $25,343,150. This represents a 11.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 2,154,820 shares of company stock valued at $195,106,438 over the last ninety days.
About Astera Labs
(
Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
See Also
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.